What is it about?
Ability of therapy to improve symptoms and quality of life and to obtain stable disease
Featured Image
Photo by Ani Kolleshi on Unsplash
Why is it important?
Ability of therapy to improve symptoms and quality of life and to obtain stable disease in heavy pretreated patient, which efficacious treatment are not disposable
Perspectives
Phase II study on resistant solid tumors
Giovanni Lo Re
Pordenone-S.Vito Oncology, CRO Aviano
Read the Original
This page is a summary of: Cyclophosphamide, Fluorouracil and subcutaneous Interleukin-2 in the treatment of advanced GIST: A Case Report, Surgical Case Reports, June 2019, Science Repository OU,
DOI: 10.31487/j.scr.2019.03.03.
You can read the full text:
Contributors
The following have contributed to this page
